Literature DB >> 7931320

Agonist and cyclic AMP-mediated regulation of beta 1-adrenergic receptor mRNA and gene transcription in rat C6 glioma cells.

K Hosoda1, G K Feussner, L Rydelek-Fitzgerald, P H Fishman, R S Duman.   

Abstract

Exposure of rat C6 glioma cells to either agonists or agents that increase cyclic AMP levels leads to down-regulation of beta 1-adrenergic receptors (beta 1 AR) as measured by loss of radioligand binding sites. The present study examines the influence of isoproterenol and forskolin treatment on levels of beta 1 AR mRNA, mRNA stability, and gene transcription rate. Isoproterenol treatment of C6 cells altered beta 1 AR mRNA levels in a biphasic manner; i.e., short-term exposure (30-60 min) increased by 50%, whereas longer exposure (2-6 h) decreased by 50% the levels of beta 1 AR mRNA. The extent of both the up- and down-regulation was dependent on agonist concentration. Similar regulation of beta 1 AR mRNA was observed in forskolin-treated cells. Pretreatment of the cells with Pseudomonas exotoxin A, a potent inhibitor of protein synthesis, completely blocked isoproterenol- and forskolin-mediated down-regulation of beta 1 AR mRNA, and thereby potentiated the increase in receptor mRNA up to fourfold over the 6-h time course. The mechanisms underlying beta 1 AR mRNA down-regulation were examined. The half-life of beta 1 AR mRNA was slightly increased (from 61 to 77 min) after a 2-h exposure of the cells to either isoproterenol or forskolin. Nuclear run-on analysis demonstrated that the rate of beta 1 AR gene transcription was increased after isoproterenol incubation for 60 min, but then decreased after 90-240 min, consistent with the time course for up- and down-regulation of beta 1 AR mRNA. Isoproterenol treatment (120 min) also decreased the level of beta 1 AR nascent transcripts, purified by affinity chromatography of RNA isolated from 4-thiouridine-pulsed cells. The results demonstrate that beta 1 AR mRNA has a relatively short half-life and that agonist regulation of beta 1 AR mRNA is mediated by activation of the cyclic AMP system. Moreover, the results indicate that agonist regulation of beta 1 AR mRNA occurs at the level of beta 1 AR gene transcription, not mRNA stability. Finally, the observed requirement for protein synthesis indicates that beta 1 AR mRNA down-regulation may be mediated by the induction of a repressor of the beta 1 AR gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7931320     DOI: 10.1046/j.1471-4159.1994.63051635.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

1.  Effects of antisense to the (alpha)2A-adrenoceptors administered into the region of the locus ceruleus on behaviors in plus-maze and sexual behavior tests in sham-operated and castrated male rats.

Authors:  G T Shishkina; T S Kalinina; N Y Sournina; N N Dygalo
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

2.  Regulation of beta-adrenoceptor density and mRNA levels in the rat heart cell-line H9c2.

Authors:  V Dangel; J Giray; D Ratge; H Wisser
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

3.  Beta-adrenoceptors in the tree shrew brain. II. Time-dependent effects of chronic psychosocial stress on [125I]iodocyanopindolol bindings sites.

Authors:  G Flügge; O Ahrens; E Fuchs
Journal:  Cell Mol Neurobiol       Date:  1997-08       Impact factor: 5.046

4.  Differential adrenergic regulation of the gene expression of the beta-adrenoceptor subtypes beta1, beta2 and beta3 in brown adipocytes.

Authors:  T Bengtsson; B Cannon; J Nedergaard
Journal:  Biochem J       Date:  2000-05-01       Impact factor: 3.857

Review 5.  Mechanisms of beta-adrenergic receptor desensitization: from molecular biology to heart failure.

Authors:  M J Lohse; S Engelhardt; S Danner; M Böhm
Journal:  Basic Res Cardiol       Date:  1996       Impact factor: 17.165

6.  Downregulation of β-Adrenoceptors in Isoproterenol-Induced Cardiac Remodeling through HuR.

Authors:  Qian Yin; Chengzhi Yang; Jimin Wu; Haiyan Lu; Xiaohui Zheng; Youyi Zhang; Zhizhen Lv; Xiaopu Zheng; Zijian Li
Journal:  PLoS One       Date:  2016-04-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.